login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Endovascular treatment for diabetic foot syndrome shows nearly 83% freedom from amputation


Thursday, 20 Oct 2011 13:51

A study first published online on 12 September in the Journal of Interventional Cardiology suggests that endovascular treatment of diabetic foot syndrome using mixed coronary and peripheral materials and techniques leads to high immediate success and limb salvage rates compared to historical series.


Authors of the study, Paolo Cardaioli, department of Interventional Cardiology, University of Padova Medical School, Padova, Italy et al set out to assess the long-term results of interventional treatment of diabetic foot using mixed coronary and peripheral equipments and techniques.


A diabetic foot exhibits any pathology that results directly from diabetes mellitus or any chronic complication of diabetes mellitus. Presence of several characteristic diabetic foot pathologies is called diabetic foot syndrome. Interventional treatment for the diabetic foot is rapidly becoming the therapy of choice for patients, but proper materials and techniques are still debated, wrote the authors.


The investigators prospectively enrolled 220 diabetic patients (78.5±15.8 years, 107 female, all with Fontaine III or IV class) from January 2006 to December 2010 who were referred to our center for diabetic foot syndrome and severe limb ischaemia. They used techniques using both coronary and peripheral guidewires and balloons. Doppler ultrasonography and foot transcutaneous oxygen pressure (TcPO2) before and after the procedure were calculated as well as the amputation rate.


Cardaioli et al point out that the preferred approach was ipsilateral femoral antegrade in 170/220 patients (77.7%), contralateral cross-over in 40/220 patients (18.8%), and popliteal retrograde plus femoral antegrade in 10/220 patients (4.5%).


They explain that the techniques included combined use of coronary and dedicated peripheral guidewires and coronary and peripheral dedicated balloons. “Percutaneous balloon angioplasty was performed in 252 legs, and contributing to these were 32 patients with bilateral disease. The procedure was successful in 239/252 legs with an immediate success rate of 94.8% and a significant improvement in TcPO2 and ankle-brachial index with ulcer healing in 233/252 legs (92.4%).” Authors wrote that the freedom from major amputation was 82.8% at a mean follow-up of 3.1±1.8 years (range one to five years).




Add New Comment

Related Items


Most popular


First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery
Friday, 26 Sep 2014
The audience in the CIRSE 2014 “Controversies in superficial femoral artery treatment” session failed to endorse two motions pertaining to drug-elution in this anatomical segment in the annual ... CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery

Features


What the trials have taught us about aggressive therapy of deep venous thrombosis
Thursday, 25 Sep 2014
Although current evidence in favour of catheter-directed thrombolysis for deep venous thrombosis may not be robust enough to allow for a shift in clinical practice, that may soon change with strict ... What the trials have taught us about aggressive therapy of deep venous thrombosis

The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Profiles


José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions